Opportunities Expanding Use in Obesity Management The growing use of GLP-1 analogues for the treatment of obesity is one of the largest opportunities
Exenatide (EC 50 = 0.60 nM, E max = 125%) and liraglutide (EC 50 = 1.8 nM, E max = 117%) were 380- and 130-fold more potent, respectively, and caused somewhat greater receptor internalization relative to PF-06882961 (Table S5)
On Days 3 and 5 after insemination, oral L-carnitine use greatly improved the quality of embryos
Combination of rs-fMRI, QSM, and ASL reveals the cerebral neurovascular coupling dysfunction is associated with cognitive decline in patients with chronic kidney disease
Without sufficient B-12, your bodys cells may struggle to receive enough oxygen, impacting mood and energy levels
10.1002/jsfa.9997 121 LiangD.MinikesA